Active surveillance: minimising treatment while maximising outcomes in testis cancer.
作者信息
Conduit Ciara, Tran Ben
机构信息
Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
出版信息
Transl Androl Urol. 2023 Sep 30;12(9):1371-1374. doi: 10.21037/tau-23-364. Epub 2023 Aug 31.
Abstract
摘要
相似文献
1
Active surveillance: minimising treatment while maximising outcomes in testis cancer.主动监测：在睾丸癌治疗中减少治疗手段同时最大化治疗效果。
Transl Androl Urol. 2023 Sep 30;12(9):1371-1374. doi: 10.21037/tau-23-364. Epub 2023 Aug 31.
2
The experience of patients with early-stage testicular cancer during the transition from active treatment to follow-up surveillance.早期睾丸癌患者从积极治疗过渡到随访监测期间的经历。
Urol Oncol. 2016 Apr;34(4):168.e11-20. doi: 10.1016/j.urolonc.2015.09.016. Epub 2015 Dec 18.
3
Feasibility of active surveillance in small testicular mass: a mini review.小睾丸肿块主动监测的可行性：一篇综述
Cent European J Urol. 2021;74(1):10-13. doi: 10.5173/ceju.2021.0268. Epub 2021 Feb 4.
4
[Diagnosis, treatment and follow-up of testicular cancer].睾丸癌的诊断、治疗及随访
Urologe A. 2017 Dec;56(12):1623-1636. doi: 10.1007/s00120-017-0543-9.
5
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer Surveillance.北卡罗来纳州的睾丸癌护理：对真实世界证据和癌症监测的影响。
Clin Genitourin Cancer. 2022 Aug;20(4):307-318. doi: 10.1016/j.clgc.2022.04.006. Epub 2022 Apr 21.
6
Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study.睾丸间质细胞瘤 83 例患者的临床表现、治疗及随访：前瞻性病例队列研究。
Hum Reprod. 2019 Aug 1;34(8):1389-1403. doi: 10.1093/humrep/dez083.
7
Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.当代对 I 期睾丸非精原细胞瘤生殖细胞肿瘤患者长期生存率的评估：初始睾丸切除术 后监测与积极治疗的人群比较。
Clin Genitourin Cancer. 2019 Dec;17(6):e1153-e1162. doi: 10.1016/j.clgc.2019.08.009. Epub 2019 Aug 21.
8
Shared-care survivorship program for testicular cancer patients: safe and feasible.睾丸癌患者共病管理生存项目：安全且可行。
ESMO Open. 2022 Jun;7(3):100488. doi: 10.1016/j.esmoop.2022.100488. Epub 2022 May 13.
9
Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel.睾丸肿瘤大小及睾丸网浸润作为临床I期睾丸精原细胞瘤监测患者复发风险的预后因素：睾丸癌指南小组的系统评价
Eur Urol. 2018 Mar;73(3):394-405. doi: 10.1016/j.eururo.2017.09.025. Epub 2017 Nov 20.
10
Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated?单侧睾丸癌患者的对侧睾丸活检程序：是否有必要？
Semin Urol Oncol. 2002 Nov;20(4):234-8. doi: 10.1053/suro.2002.36980.
本文引用的文献
1
Novel approaches to redesign surveillance strategies following orchiectomy for localized testicular cancer: a narrative review.睾丸局部切除术后重新设计监测策略的新方法：一项叙述性综述
Transl Androl Urol. 2023 Jun 30;12(6):1016-1022. doi: 10.21037/tau-22-855. Epub 2023 May 24.
2
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations.澳大利亚临床Ⅰ期睾丸癌患者的复发模式：澳大利亚和新西兰泌尿生殖系统及前列腺癌试验组监测推荐的实用性。
JCO Oncol Pract. 2023 Nov;19(11):973-980. doi: 10.1200/OP.23.00191. Epub 2023 Jun 16.
3
European Association of Urology Guidelines on Testicular Cancer: 2023 Update.欧洲泌尿外科学会睾丸癌指南：2023 年更新版。
Eur Urol. 2023 Sep;84(3):289-301. doi: 10.1016/j.eururo.2023.04.010. Epub 2023 May 12.
4
Testicular self-examination for early detection of testicular cancer.睾丸自我检查，以早期发现睾丸癌。
World J Urol. 2023 Apr;41(4):941-951. doi: 10.1007/s00345-023-04381-4. Epub 2023 Apr 10.
5
Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and Interventions.癌症成年患者的扫描焦虑：一项指导研究与干预的范围综述
Cancers (Basel). 2023 Feb 22;15(5):1381. doi: 10.3390/cancers15051381.
6
Shared-care survivorship program for testicular cancer patients: safe and feasible.睾丸癌患者共病管理生存项目：安全且可行。
ESMO Open. 2022 Jun;7(3):100488. doi: 10.1016/j.esmoop.2022.100488. Epub 2022 May 13.
7
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.预测转移性非精原细胞瘤生殖细胞肿瘤（NSGCT）男性患者的结局：国际生殖细胞肿瘤协作组更新联盟的结果。
J Clin Oncol. 2021 May 10;39(14):1563-1574. doi: 10.1200/JCO.20.03296. Epub 2021 Apr 6.
8
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.转移性精原细胞瘤的生存和新预后因素：IGCCCG 更新联盟的研究结果。
J Clin Oncol. 2021 May 10;39(14):1553-1562. doi: 10.1200/JCO.20.03292. Epub 2021 Mar 17.
9
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.111 研究：一项单臂、3 期临床试验，评估博来霉素、依托泊苷和顺铂作为高危 1 期非精原细胞瘤或混合生殖细胞肿瘤的辅助化疗。
Eur Urol. 2020 Mar;77(3):344-351. doi: 10.1016/j.eururo.2019.11.022. Epub 2020 Jan 1.
10
Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline.早期睾丸癌的诊断与治疗：AUA 指南。
J Urol. 2019 Aug;202(2):272-281. doi: 10.1097/JU.0000000000000318. Epub 2019 Jul 8.
Zotero 插件